Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 1, 2009, Pages 52-56

  Nakamura, Kazuo ^a   Yamagishi, Sho Ichi ^a   Adachi, Hisashi ^a   Kurita Nakamura, Yayoi ^b   Matsui, Takanori ^a   Inoue, Hiroyoshi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nakamura Clinic   (Japan)

Author keywords

Atherosclerosis; Diabetes; Obesity; PEDF

Indexed keywords

CREATININE; PIGMENT EPITHELIUM DERIVED FACTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; EYE PROTEIN; LEPTIN; MESSENGER RNA; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR; SERUM AMYLOID A;

ABDOMINAL OBESITY; ADIPOCYTE; AGED; ANTHROPOMETRY; ARTICLE; BLOOD ANALYSIS; BODY MASS; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRAABDOMINAL FAT; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; BLOOD; FOLLOW UP; GENETICS; HISTOLOGY; JAPAN; MIDDLE AGED; OBESITY; PHYSIOLOGY; REGRESSION ANALYSIS; TIME; VISCERA;

ADIPOCYTES; ADIPOSE TISSUE; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; EYE PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NERVE GROWTH FACTORS; OBESITY; REGRESSION ANALYSIS; RNA, MESSENGER; SERPINS; SERUM AMYLOID A PROTEIN; TIME FACTORS; VISCERA;

EID: 65549162987     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.820     Document Type: Article

References (21)

1. Tombran-Tink J, Chader CG, Johnson LV. PEDF: pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991; 53: 411-414.
2. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285: 245-248.
3. Duh EJ, Yang HS, Suzuma I, et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 2002; 43: 821-829.
4. Spranger J, Osterhoff M, Reimann M, et al. Loss of antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 2002; 50: 2641-2645.
5. Yamagishi S, Inagaki Y, Nakamura K, et al. Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation. J Mol Cell Cardiol 2004; 37: 497-506.
6. Yamagishi S, Nakamura K, Ueda S, Kato S, Imaizumi T. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF. Cell Tissue Res 2005; 320: 437-445.
7. Yamagishi SI, Kikuchi S, Nakamura K, et al. Pigment epithelium-derived factor (PEDF) blocks angiotensin II-induced T cell adhesion to endothelial cells by suppressing intercellular adhesion molecule-1. Horm Metab Res 2006; 38: 546-548.
8. Inagaki Y, Yamagishi S, Okamoto T, Takeuchi M, Amano S. Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation. Diabetologia 2003; 46: 284-287.
9. Yamagishi S, Nakamura K, Matsui T, et al. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 2006; 281: 20213-20220.
10. Yamagishi S, Matsui T, Nakamura K, Takeuchi M, Imaizumi T. Pigment epithelium-derived factor (PEDF) prevents diabetes-or advanced glycation end products (AGE)-elicited retinal leukostasis. Microvasc Res 2006; 72: 86-90.
11. Yamagishi S, Adachi H, Abe A, et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 2006; 91: 2447-2450.
12. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 183-197.
13. Motomiya Y, Yamagishi S, Adachi H, Abe A. Increased serum concentrations of pigment epithelium-derived factor in patients with end-stage renal disease. Clin Chem 2006; 52: 1970-1971.
14. Kratchmarova I, Kalume DE, Blagoev B, et al. A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol Cell Proteomics 2002; 1: 213-222.
15. Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006; 3: 35-42.
16. Tombran-Tink J, Mazuruk K, Rodriguez IR, et al. Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis 1996; 4: 11.
17. Singh VK, Chader GJ, Rodriguez IR. Structural and comparative analysis of themouse gene for pigment epithelium-derived factor (PEDF). Mol Vis 1998; 20: 7.
18. Ponsuksili S, Murani E, Schellander K, Schwerin M, Wimmers K. Identification of functional candidate genes for body composition by expression analyses and evidencing impact by association analysis and mapping. Biochim Biophys Acta 2005; 1730: 31-40.
19. Kadowaki T, Sekikawa A, Murata K, et al. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int J Obes 2006; 30: 1163-1165.
20. Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007; 101: 545-559.
21. Poitou C, Viguerie N, Cancello R, et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 2005; 48: 519-528.